Nice analogy Ken. Nobody cares about our asses. They just

New Post Public Reply Private Reply Replies (1) Message Board
Goosebumps KenChowder #89676
495
Nice analogy Ken. Nobody cares about our asses. They just want us to sell sell sell.

As for giving away doses for the quick results that may speed up an EUA somewhere. I am not opposed to that within reason. The cost of doses are minimal at $75 a dose manufacturing cost. Now that doesn’t factor in our cost of research for covid or any other indication going forward, just bare manufacturing but a reasonable amount of free doses could progress the speed of science. That’s the goal and what is that worth? Call it free advertising when expected results shine and notoriety of a drug that works spreads around the world. It’s like lighting a fuse. Save lives and people notice. People say when you save lives you don’t need to advertise.

Consider it an advertising budget. What’s that worth? 10,000 doses is only $750,000. What is the return on that spent? That’s the question... maybe a smaller amount is being to conservative and shows not enough anecdotal evidence yet again. We can tell and scream about how good Leronlimab is but we need the people that have used it successfully to tell and scream for us.

I say light the fuse... I am optimistic about giving away doses. 400 doses are nothing to me. Give away 10,000 doses and maybe add in some protocols to track and see what happens. It can’t hurt to try a new approach. We need better results some way? Maybe split the doses 5,000 each for Philippines and Brazil. Then see how fast the trials fill up.

How many doses did Remdeathisnear give away? It was a lot. I think it was 40,000 but I am not sure. I should Google it. But someone else can.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Important Legal Opportunity for Coinbase Investors in Class Action

Updated Category News Views 114

Key Opportunity for Coinbase Investors Investors holding Coinbase Global, Inc. (NASDAQ: COIN) securities may have a significant opportunity to participate in a class action lawsuit alleging serious violations of securities regulations. This opportunity arises from actions that took place during the specified Class Period. Investors are encouraged to evaluate their...

Continue Reading
BridGene Biosciences Secures $28 Million for Drug Development

Updated Category News Views 244

BridGene Biosciences Raises Significant Funding BridGene Biosciences, Inc., renowned for its innovative approach in developing small molecule drugs, recently announced the completion of a substantial $28 million Series B+ financing round. This funding round was spearheaded by Bayland Capital, alongside notable contributions from GTJA Investment Group, Proxima Ventures,...

Continue Reading
NMD Pharma Breaks Ground with NMD670 in Rare Neuromuscular Treatment

Updated Category News Views 177

NMD Pharma's Innovative Phase 2 Study with NMD670 NMD Pharma A/S, an ambitious clinical-stage biotech company, is making strides in the fight against neuromuscular diseases. They have officially begun their Phase 2a clinical trial of NMD670, a novel treatment aimed at addressing the challenges faced by patients with Charcot-Marie-Tooth (CMT) disease types 1 and 2. This...

Continue Reading
Becker Milk Company Limited Announces Half-Year Financial Overview

Updated Category News Views 89

Introduction to Becker Milk Company's Financial Landscape Becker Milk Company Limited is making headlines with its financial results for the first half of its fiscal year. The latest report showcases their performance, reflecting on revenues and net income trends. Financial Highlights Overview Total revenues for the first six months reveal a detail-oriented insight into...

Continue Reading
Mini Melts Collaborates with 7-Eleven for Blue Raspberry Flavor

Updated Category News Views 354

Exciting New Flavor Launch from Mini Melts and 7-Eleven In an exciting collaboration, Mini Melts USA, a leader in premium beaded ice cream, has partnered with 7-Eleven, Inc. to introduce a new flavor reminiscent of the classic Blue Raspberry Slurpee. This innovative flavor captures the essence of the much-loved frozen drink, providing fans with a delightful and nostalgic...

Continue Reading